Format
Sort by

Send to:

Choose Destination

Results: 5

Related Articles by Review for PubMed (Select 20519360)

1.

A novel nanoparticulate formulation of arsenic trioxide with enhanced therapeutic efficacy in a murine model of breast cancer.

Ahn RW, Chen F, Chen H, Stern ST, Clogston JD, Patri AK, Raja MR, Swindell EP, Parimi V, Cryns VL, O'Halloran TV.

Clin Cancer Res. 2010 Jul 15;16(14):3607-17. doi: 10.1158/1078-0432.CCR-10-0068. Epub 2010 Jun 2.

2.

Cell-penetrating properties of the transactivator of transcription and polyarginine (R9) peptides, their conjugative effect on nanoparticles and the prospect of conjugation with arsenic trioxide.

Kanwar JR, Gibbons J, Verma AK, Kanwar RK.

Anticancer Drugs. 2012 Jun;23(5):471-82. doi: 10.1097/CAD.0b013e32835065ed. Review.

PMID:
22241171
3.

Arsenic trioxide - An old drug rediscovered.

Emadi A, Gore SD.

Blood Rev. 2010 Jul-Sep;24(4-5):191-9. doi: 10.1016/j.blre.2010.04.001. Epub 2010 May 15. Review.

4.

Mechanisms of action of arsenic trioxide.

Miller WH Jr, Schipper HM, Lee JS, Singer J, Waxman S.

Cancer Res. 2002 Jul 15;62(14):3893-903. Review.

5.

Arsenic trioxide in the treatment of haematological malignancies.

Kwong YL.

Expert Opin Drug Saf. 2004 Nov;3(6):589-97. Review.

PMID:
15500417
Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk